Benzinga - Mon, 19 Apr 2021 13:16:36 -0400
Benzinga - Fri, 16 Apr 2021 13:00:36 -0400
Benzinga - Fri, 16 Apr 2021 08:10:46 -0400
Benzinga - Tue, 13 Apr 2021 10:04:03 -0400
Benzinga - Tue, 13 Apr 2021 05:18:31 -0400
Benzinga - Mon, 12 Apr 2021 12:00:14 -0400
Benzinga - Mon, 12 Apr 2021 10:01:54 -0400
Benzinga - Mon, 12 Apr 2021 08:14:23 -0400
Benzinga - Mon, 12 Apr 2021 07:40:01 -0400
Benzinga - Mon, 12 Apr 2021 07:02:10 -0400
load more
Sector: Health Care.Industry: Biotechnology
Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-21
REV
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-21
REV

Related Companies

TickerCompanyChg %Mkt Cap
QLGNQualigen Therapeutics0.54%53.9M

Qualigen Therapeutics Company Questions & Answers

Q

How do I buy Qualigen Therapeutics (QLGN) stock?

A

You can purchase shares of Qualigen Therapeutics (NASDAQ: QLGN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Qualigen Therapeutics's (QLGN) main competitors?

A

Other companies in Qualigen Therapeutics’s space includes: Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC) and Brickell Biotech (NASDAQ:BBI).

Q

What is the target price for Qualigen Therapeutics?

A

There is no analysis for Qualigen Therapeutics

Q

How much is Qualigen Therapeutics (QLGN) stock ?

A

The stock price for Qualigen Therapeutics (NASDAQ: QLGN) is $1.87 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Qualigen Therapeutics (QLGN) dividend?

A

There are no upcoming dividends for Qualigen Therapeutics.

Q

When is Qualigen Therapeutics (NASDAQ:QLGN) reporting earnings?

A
Qualigen Therapeutics’s Q3 earnings are confirmed after-market from now on May 21, 2021.
Q

When is the upcoming split for QLGN?

A

There is no upcoming split for Qualigen Therapeutics.